BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Third Quarter 2026 Results

Progyny (PGNY)ProgynyEarnings

Reports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net Income Selling Season Yields Record 1.3 Million New Covered Lives with Another Year of Near 100% Retention Raises Midpoint of Full Year Guidance Ranges NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc.

Related news

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2025-11-06 21:01 EST

Progyny, Inc. Announces Third Quarter 2025 Results

HSTMHealthStream2025-11-03 21:30 EST

HealthStream Announces Third Quarter 2025 Results

FEMYFEMASYS2025-11-14 21:01 EST

Femasys Announces Third Quarter Financial Results for 2025

HSTMHealthStream2026-11-02 21:30 EST

HealthStream Announces Third Quarter 2026 Results

TDOCTeladoc2026-10-28 20:05 EST

Teladoc Health Reports Third Quarter 2026 Results

FEMYFEMASYS2026-08-14 20:05 EST

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

TXMDTherapeuticsMD2025-11-12 21:05 EST

TherapeuticsMD Announces Third Quarter 2025 Financial Results

TXMDTherapeuticsMD2024-11-12 21:05 EST

TherapeuticsMD Announces Third Quarter 2024 Financial Results

SERASera Prognostics2026-11-04 21:05 EST

SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-11-04 21:01 EST

Progyny, Inc. Announces Third Quarter 2026 Results

PGNYProgyny2026-10-28 13:52 EST

New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

PGNYProgyny2026-10-26 15:25 EST

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2026-10-15 13:35 EST

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Stock data

Close
34.37 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States